Rita has diabetes, discovered her daughter does too. Portugal awaits innovative drug that delays need for insulin
The APDP (Associação Protetora dos Diabéticos de Portugal) conducts free screenings for Type 1 diabetes in children aged 3 to 17, identifying the disease before symptoms appear. While the drug Teplizumab has received a positive opinion from Infarmed for delaying the need for insulin by approximately 2.5 years in early-stage patients, it is not yet available for use in the national health system.
